Patents by Inventor Rong Zhang

Rong Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6870069
    Abstract: A phenyloxyaniline derivative useful as a ligand for peripheral benzodiazepine receptor having a strong affinity and a high selectivity, which is represented by formula (1): wherein X1 and X2 are same or different and each is hydrogen atom or halogen atom; R1 and R2 are same or different and each is hydrogen atom, an alkyl group having 1 to 10 carbon(s) or a halogen-substituted alkyl group having 1 to 10 carbon(s); and R3 is a halogen-substituted alkyl group having 1 to 5 carbon(s), or a radioisotope thereof.
    Type: Grant
    Filed: November 4, 2003
    Date of Patent: March 22, 2005
    Assignees: National Institute of Radiological Sciences, Taisho Pharmaceutical Co., Ltd., Nihon Nohyaku Co., Ltd.
    Inventors: Kazutoshi Suzuki, Ming-Rong Zhang, Tetsuya Suhara, Atsuro Nakazato, Makoto Goto
  • Publication number: 20040167123
    Abstract: The present invention provides an HCV polymerase inhibiting compound having the formula (I) 1
    Type: Application
    Filed: October 31, 2003
    Publication date: August 26, 2004
    Inventors: John K. Pratt, David A. Betebenner, Pamela L. Donner, Brian E. Green, Dale J. Kempf, Keith F. McDaniel, Clarence J. Maring, Vincent S. Stoll, Rong Zhang
  • Publication number: 20040162285
    Abstract: Compounds having the formula 1
    Type: Application
    Filed: July 23, 2003
    Publication date: August 19, 2004
    Inventors: John K. Pratt, David A. Betebenner, Pamela L. Donner, Brian E. Green, Dale J. Kempf, Keith F. McDaniel, Clarence J. Maring, Vincent S. Stoll, Rong Zhang
  • Publication number: 20040138310
    Abstract: A phenyloxyaniline derivative useful as a ligand for peripheral benzodiazepine receptor having a strong affinity and a high selectivity, which is represented by formula (1): 1
    Type: Application
    Filed: November 4, 2003
    Publication date: July 15, 2004
    Applicants: NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES, TAISHO PHARMACEUTICAL CO., LTD., NIHON NOHYAKU CO., LTD.
    Inventors: Kazutoshi Suzuki, Ming-Rong Zhang, Tetsuya Suhara, Atsuro Nakazato, Makoto Goto
  • Publication number: 20040097492
    Abstract: Compounds having the formula 1
    Type: Application
    Filed: November 1, 2002
    Publication date: May 20, 2004
    Inventors: John K. Pratt, David A. Betebenner, Pamela L. Donner, Brian E. Green, Dale J. Kempf, Keith F. McDaniel, Clarence J. Maring, Vincent S. Stoll, Rong Zhang
  • Publication number: 20040087577
    Abstract: Compounds having the formula 1
    Type: Application
    Filed: April 10, 2003
    Publication date: May 6, 2004
    Inventors: John K. Pratt, David A. Betebenner, Pemela L. Donner, Brian E. Green, Dale J. Kempf, Keith F. McDaniel, Clarence J. Maring, Vincent S. Stoll, Rong Zhang
  • Patent number: 6710200
    Abstract: Ethers and esters of cyanohydrins that contain optically detectable moieties are highly effective for detecting, monitoring, and measuring the activity of enzymes that cause the cleavage of certain types of substrates. The cyanohydrins function as proaldehydes and proketones, spontaneously converting to aldehydes and ketones, respectively, which provide a large increase in optical detectability relative to both the starting esters and ethers and the cyanohydrins.
    Type: Grant
    Filed: January 7, 2003
    Date of Patent: March 23, 2004
    Assignee: The Regents of the University of California
    Inventors: Bruce D. Hammock, Guomin Shan, Rong Zhang
  • Publication number: 20040042466
    Abstract: The present invention provides a system and method for enabling the synchronization of a switch and an interface device. Based on a comparison of cell sequence numbers included in cells received from the interface device to a current cell time within the switch, cell time adjustment information can be transmitted to the interface device. The cell time adjustment information is used by the interface device to determine the cell sequence number that is included in cells transmitted to the switch.
    Type: Application
    Filed: August 30, 2002
    Publication date: March 4, 2004
    Inventors: James E. Tatem,, Randy A. Drago, Chi-Yu Lu, Son Truong Ngo, Rong Zhang, Vahid Tabatabaee, Kirby Lee Nell
  • Publication number: 20040039608
    Abstract: The present invention provides a computer-implemented system and method for providing a post employment qualified health care benefit plan funded during a covered person's working years to covered persons under the plan. The method having the steps of providing a computer system to manipulate and process a plurality of predefined variables; electing a number of benefit payout years for receiving benefits during a payout period; electing either a standard non-lump-sum premium option or a lump sum premium option; electing standard non-lump-sum variables under the standard non-lump-sum premium option; electing lump sum variables under the lump sum premium option; using the computer system to calculate a schedule of premiums based on the standard non-lump-sum variables and the lump sum variables to obtain an associated maximum benefit amount; and paying a maximum benefit amount for qualified health expenses upon occurrence of a triggering event.
    Type: Application
    Filed: June 21, 2002
    Publication date: February 26, 2004
    Applicant: Lulac, LLC
    Inventors: Christopher Mazur, Rong Zhang, Susan Weinrauch, Susan LaFreniere, John Simmons
  • Publication number: 20030207344
    Abstract: Ethers and esters of cyanohydrins that contain optically detectable moieties are highly effective for detecting, monitoring, and measuring the activity of enzymes that cause the cleavage of certain types of substrates. The cyanohydrins function as proaldehydes and proketones, spontaneously converting to aldehydes and ketones, respectively, which provide a large increase in optical detectability relative to both the starting esters and ethers and the cyanohydrins.
    Type: Application
    Filed: January 7, 2003
    Publication date: November 6, 2003
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Bruce D. Hammock, Guomin Shan, Rong Zhang
  • Patent number: 6528675
    Abstract: Ethers and esters of cyanohydrins that contain optically detectable moieties are highly effective for detecting, monitoring, and measuring the activity of enzymes that cause the cleavage of certain types of substrates. The cyanohydrins function as proaldehydes and proketones, spontaneously converting to aldehydes and ketones, respectively, which provide a large increase in optical detectability relative to both the starting esters and ethers and the cyanohydrins.
    Type: Grant
    Filed: October 3, 2001
    Date of Patent: March 4, 2003
    Assignee: The Regents of the University of California
    Inventors: Bruce D. Hammock, Guomin Shan, Rong Zhang
  • Patent number: 5480526
    Abstract: The present invention provides new methods for desalting samples of ionic polymers or weak electrolytes, preferable ampholytes (e.g., peptides, proteins and glycoconjugates) or, compounds which can be transformed into these substances by complex formation. The methods of the present invention are based on the fact that salts can be removed from a sample by electrophoretically replacing the salts with ampholytes present in the ampholytic media of the anolyte and the catholyte or, with displacing cations and anions that have been introduced into the anolyte and catholyte, respectively, and which have mobilities less than the mobilities of the cations and anions to be removed from the sample.Although applicable to both small-volume and large-volume samples, the methods are particularly well suited for small-volume samples. Moreover, when applied to capillary electrophoresis, the methods described herein permit desalting of a sample in the same capillary tube as is used for the electrophoretic analysis.
    Type: Grant
    Filed: June 7, 1994
    Date of Patent: January 2, 1996
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Jia-li Liao, Rong Zhang, Christopher Siebert